Association of sarcopenia with short- and long-term mortality in older adults admitted to acute care wards: Results from the CRIME study

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 69, Issue 9, 2014, Pages 1154-1161

  Vetrano, Davide L ^a   Landi, Francesco ^a   Volpato, Stefano ^b   Corsonello, Andrea ^c   Meloni, Eleonora ^a   Bernabei, Roberto ^a   Onder, Graziano ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c INRCA   (Italy)

Author keywords

Acute care; Frailty; Mortality; Physical performance; Sarcopenia

Indexed keywords

ARTICLE; EMERGENCY CARE; FEMALE; FRAILTY; HOSPITAL PATIENT; HUMAN; MALE; MORTALITY; MULTICENTER STUDY (TOPIC); PHYSICAL PERFORMANCE; SARCOPENIA; VERY ELDERLY;

ACUTE CARE; FRAILTY; MORTALITY; PHYSICAL PERFORMANCE; SARCOPENIA;

AGED, 80 AND OVER; FEMALE; HUMANS; INPATIENTS; MALE; MULTICENTER STUDIES AS TOPIC; SARCOPENIA;

EID: 84906224057     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glu034     Document Type: Article

References (51)

1. Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci. 2002;57(12):M772-M777. doi:10.1093/gerona/57.12
2. Landi F, Liperoti R, Russo A, et al. Sarcopenia as a risk factor for falls in elderly individuals: Results from the ilSIRENTE study. Clin Nutr. 2012;31(5):652-658. doi:10.1016/j.clnu.2012.02.007
3. Janssen I, Ross R. Linking age-related changes in skeletal muscle mass and composition with metabolism and disease. J Nutr Health Aging. 2005;9(6):408-419
4. Cederholm T, Cruz-Jentoft AJ, Maggi S. Sarcopenia and fragility fractures. Eur J Phys Rehabil Med. 2013;49(1):111-117
5. Janssen I. Influence of sarcopenia on the development of physical disability: The Cardiovascular Health Study. J Am Geriatr Soc. 2006;54(1):56-62
6. Fried LP, Tangen CM, Walston J, et al.; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146-M156
7. Rosenberg I. Summary comments: Epidemiological and methodological problems in Determining nutritional status of older persons. Am J Clin Nutr. 1989;50:1231-1233
8. Cruz-Jentoft AJ, Landi F, Topinková E, Michel JP. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care. 2010;13(1):1-7. doi:10.1097/MCO.0b013e328333c1c1
9. Landi F, Liperoti R, Russo A, et al. Association of anorexia with sarcopenia in a community-dwelling elderly population: Results from the ilSIRENTE study. Eur J Nutr. 2013;52(3):1261-1268. doi:10.1007/s00394-012-0437-y
10. Murphy RA, Ip EH, Zhang Q, et al.; Health, Aging, and Body Composition Study. Transition to sarcopenia and determinants of transitions in older adults: A population-based study. J Gerontol A Biol Sci Med Sci. September 7, 2013 [Epub ahead of print]. PMID: 24013673
11. Sinha-Hikim I, Sinha-Hikim AP, Parveen M, et al. Long-Term supplementation with a cystine-based antioxidant delays loss of muscle mass in aging. J Gerontol A Biol Sci Med Sci. 2013;68(7):749-759. doi:10.1093/gerona/ gls334
12. Vetrano DL, Landi F, De Buyser SL, et al. Predictors of length of hospital stay among older adults admitted to acute care wards: A multicentre observational study. Eur J Intern Med. 2014;25(13):56-62. doi:10.1016/j.ejim. 2013.08.709
13. Arango-Lopera VE, Arroyo P, Gutiérrez-Robledo LM, Pérez-Zepeda MU, Cesari M. Mortality as an adverse outcome of sarcopenia. J Nutr Health Aging. 2013;17(3):259-262. doi:10.1007/s12603-012-0434-0
14. Fusco D, Lattanzio F, Tosato M, et al. Development of CRIteria to assess appropriate Medication use among Elderly complex patients (CRIME) project: Rationale and methodology. Drugs Aging. 2009;26(suppl 1):3-13. doi:10.2165/11534620-000000000-00000
15. Tosato M, Settanni S, Antocicco M, et al. Pattern of medication use among older inpatients in seven hospitals in Italy: Results from the CRiteria to assess Appropriate Medication use among Elderly complex patients (CRIME) project. Curr Drug Saf. 2013;8:98-103
16. Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: Results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc. 2002;50:1962-1968
17. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al.; European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on Definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412-423. doi:10.1093/ageing/afq034
18. Lauretani F, Russo CR, Bandinelli S, et al. Age-Associated changes in skeletal muscles and their effect on mobility: An operational diagnosis of sarcopenia. J Appl Physiol (1985). 2003;95:1851-1860
19. Hillman TE, Nunes QM, Hornby ST, et al. A practical posture for hand grip dynamometry in the clinical setting. Clin Nutr. 2005;24:224-228
20. Bosaeus I, Wilcox G, Rothenberg E, Strauss BJ. Skeletal muscle mass in hospitalized elderly patients: Comparison of measurements by single-frequency BIA and DXA. Clin Nutr. June 18, 2013. doi:10.1016/j. clnu.2013.06.007
21. Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol (1985). 2000;89(2):465-471
22. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychosocial function. JAMA. 1963;185:914-919
23. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198
24. Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. Clin Gerontol. 1986;5(1/2):165-173. doi:10.3109/09638288.2010.503835
25. WHO. Physical Status: The Use and Interpretation Of Anthropometry. Report of a WHO Expert Consultation. WHO Technical Report Series Number 854. Geneva, Switzerland: World Health Organization; 1995
26. WHO Collaborating Center for Drug Statistics Methodology. http://www.whocc.no/. Accessed July 15, 2013
27. Vetrano DL, Tosato M, Colloca G, et al.; SHELTER Study. Polypharmacy in nursing home residents with severe cognitive impairment: Results from the SHELTER Study. Alzheimers Dement. 2013;9:587-593. doi:10.1016/j.jalz.2012.09.009
28. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40:373-383
29. Volpato S, Cavalieri M, Sioulis F, et al. Predictive value of the Short Physical Performance Battery following hospitalization in older patients. J Gerontol A Biol Sci Med Sci. 2011;66(1):89-96. doi:10.1093/gerona/glq167
30. Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12(4):249-256. doi:10.1016/j.jamda.2011.01.003
31. Delmonico MJ, Harris TB, Visser M, et al.; Health, Aging, and Body. Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr. 2009;90(6):1579-1585. doi:10.3945/ajcn.2009.28047
32. Janssen I. Evolution of sarcopenia research. Appl Physiol Nutr Metab. 2010;35(5):707-712. doi:10.1139/H10-067
33. Landi F, Onder G, Bernabei R. Sarcopenia and diabetes: Two sides of the same coin. J Am Med Dir Assoc. 2013;14:540-541. doi:10.1016/j. jamda.2013.05.004
34. Landi F, Marzetti E, Liperoti R, et al. Nonsteroidal anti-inflammatory drug (NSAID) use and sarcopenia in older people: Results from the ilSIRENTE study. J Am Med Dir Assoc. 2013;14(8):626.e9-13. doi:10.1016/j.jamda.2013.04.012
35. Barillaro C, Liperoti R, Martone AM, Onder G, Landi F. The new metabolic treatments for sarcopenia. Aging Clin Exp Res. 2013;25(2):119-127. doi:10.1007/s40520-013-0030-0
36. Carter CS, Marzetti E, Leeuwenburgh C, et al. Usefulness of preclinical models for assessing the efficacy of late-life interventions for sarcopenia. J Gerontol A Biol Sci Med Sci. 2012;67(1):17-27. doi:10.1093/gerona/glr042
37. Honda H, Qureshi AR, Axelsson J, et al. Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. Am J Clin Nutr. 2007;86(3):633-638
38. Houston DK, Nicklas BJ, Ding J, et al.; Health ABC Study. Dietary protein intake is associated with lean mass change in older, community-dwelling adults: The Health, Aging, and Body Composition (Health ABC) Study. Am J Clin Nutr. 2008;87(1):150-155
39. Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004;52(1):80-85
40. Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol. 2004;159(4):413-421
41. Cawthon PM, Fox KM, Gandra SR, et al.; Health, Aging and Body Composition Study. Do muscle mass, muscle density, strength, and physical function similarly influence risk of hospitalization in older adults?. J Am Geriatr Soc. 2009;57(8):1411-1419. doi:10.1111/j.1532-5415.2009.02366.x
42. Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: A call to action. J Am Med Dir Assoc. 2013;14(6):392-397. doi:10.1016/j. jamda.2013.03.022
43. Gariballa S, Alessa A. Sarcopenia: Prevalence and prognostic significance in hospitalized patients. Clin Nutr. 2013;32:772-776. doi:10.1016/j.clnu.2013. 01.010
44. Landi F, Liperoti R, Fusco D, et al. Prevalence and risk factors of sarcopenia among nursing home older residents. J Gerontol A Biol Sci Med Sci. 2012;67(1):48-55. doi:10.1093/gerona/glr035
45. Patil R, Uusi-Rasi K, Pasanen M, Kannus P, Karinkanta S, Sievänen H. Sarcopenia and osteopenia among 70-80-year-old home-dwelling Finnish women: Prevalence and association with functional performance. Osteoporos Int. 2013;24(3):787-796. doi:10.1007/s00198-012-2046-2
46. Volpato S, Bianchi L, Cherubini A, et al. Prevalence and clinical correlates of sarcopenia in community-dwelling older people: Application of the EWGSOP definition and diagnostic algorithm. J Gerontol A Biol Sci Med Sci. 2014;69(4):438-446. doi:10.1093/gerona/glt149
47. Landi F, Cruz-Jentoft AJ, Liperoti R, et al. Sarcopenia and mortality risk in frail older persons aged 80 years and older: Results from ilSIRENTE study. Age Ageing. 2013;42(2):203-209. doi:10.1093/ageing/afs194
48. Landi F, Liperoti R, Fusco D, et al. Sarcopenia and mortality among older nursing home residents. J Am Med Dir Assoc. 2012;13(2):121-126. doi:10.1016/j.jamda.2011.07.004
49. Cesari M, Pahor M, Lauretani F, et al. Skeletal muscle and mortality results from the InCHIANTI Study. J Gerontol A Biol Sci Med Sci. 2009;64(3):377-384. doi:10.1093/gerona/gln031
50. Mijnarends DM, Meijers JM, Halfens RJ, et al. Validity and reliability of tools to measure muscle mass, strength, and physical performance in community-dwelling older people: A systematic review. J Am Med Dir Assoc. 2013;14(3):170-178. doi:10.1016/j. jamda.2012.10.009
51. Wells JC, Fewtrell MS. Measuring body composition. Arch Dis Child. 2006;91:612-617